Belda, Mizzy Lyn B.
HRN: 25-52-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/03/2025
08/10/2025
IV
200mg
Q6h
Submandibular Abscess, Left
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines